Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileDaniel Tarsy, M.D.

TitleProfessor of Neurology
InstitutionBeth Israel Deaconess Medical Center
DepartmentNeurology
AddressBeth Israel Deaconess Med Ctr
Neurology
330 Brookline Ave
Boston MA 02215
Phone617/667-0519
Fax617/975-5454
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Tarsy D. Addition of a virtual reality component to treadmill training to reduce fall risk in older adults, including individuals with Parkinson's disease. Mov Disord. 2016 Nov; 31(11):1632. PMID: 27759893.
    View in: PubMed
  2. Graebner AK, Tarsy D, Shih LC, Vanderhorst V, Kulkarni O, Kaplan S, Simon DK. Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center. Neurodegener Dis. 2017; 17(1):38-43. PMID: 27614874.
    View in: PubMed
  3. Narayanaswami P, Geisbush T, Tarulli A, Raynor E, Gautam S, Tarsy D, Gronseth G. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins. Parkinsonism Relat Disord. 2016 Sep; 30:73-7. PMID: 27406786.
    View in: PubMed
  4. Parihar R, Alterman R, Papavassiliou E, Tarsy D, Shih LC. Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor. Tremor Other Hyperkinet Mov (N Y). 2015; 5:321. PMID: 26196027; PMCID: PMC4502347.
  5. Smith KM, O'Connor M, Papavassiliou E, Tarsy D, Shih LC. Phonemic verbal fluency decline after subthalamic nucleus deep brain stimulation does not depend on number of microelectrode recordings or lead tip placement. Parkinsonism Relat Disord. 2014 Apr; 20(4):400-4. PMID: 24495709.
    View in: PubMed
  6. Nutt JG, Siderowf AD, Guttman M, Schmidt PN, Zamudio JI, Wu SS, Okun MS, Simuni T, Parashos SA, Dahodwala NA, Davis TL, Giladi N, Gurevich T, Hauser RA, Jankovic J, Lyons KE, Marsh L, Miyasaki JM, Morgan JC, Santiago AJ, Tarsy D, Mari Z, Malaty IA, Nelson EC. Mobility, mood and site of care impact health related quality of life in Parkinson's disease. Parkinsonism Relat Disord. 2014 Mar; 20(3):274-9. PMID: 24182524.
    View in: PubMed
  7. Kaplan S, Tarsy D. Initial treatment of Parkinson's disease: an update. Curr Treat Options Neurol. 2013 Aug; 15(4):377-84. PMID: 23645294.
    View in: PubMed
  8. Shih LC, Tarsy D, Okun MS. The current state and needs of north american movement disorders fellowship programs. Parkinsons Dis. 2013; 2013:701426. PMID: 23984186; PMCID: PMC3745959.
  9. Sengupta S, Tarsy D, Joyce R, Jeyapalan S. Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant. Mov Disord. 2013 Nov; 28(13):1905-6. PMID: 23839936.
    View in: PubMed
  10. Kulkarni OC, Cox CA, Hedges TR, Tarsy D. Sternutatory reflex induced by periocular needle insertion in patients receiving chronic botulinum toxin injections. Parkinsonism Relat Disord. 2013 Aug; 19(8):770-1. PMID: 23680422.
    View in: PubMed
  11. Kulkarni O, Lafaver K, Tarsy D. The "floating door sign" in Parkinson's disease. Parkinsonism Relat Disord. 2013 Sep; 19(9):825-6. PMID: 23660546.
    View in: PubMed
  12. Shih LC, LaFaver K, Lim C, Papavassiliou E, Tarsy D. Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it? Parkinsonism Relat Disord. 2013 Jul; 19(7):676-9. PMID: 23582712.
    View in: PubMed
  13. Kulkarni O, Lafaver K, Papavassiliou E, Tarsy D, Shih LC. Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved? Mov Disord. 2013 Apr; 28(4):554-5. PMID: 23389961.
    View in: PubMed
  14. Fasano A, Valadas A, Bhatia KP, Prashanth LK, Lang AE, Munhoz RP, Morgante F, Tarsy D, Duker AP, Girlanda P, Bentivoglio AR, Espay AJ. Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord. 2012 Oct; 27(12):1544-51. PMID: 23033125; PMCID: PMC3633239.
  15. Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, Watts R, Zesiewicz T. Reliability of a new scale for essential tremor. Mov Disord. 2012 Oct; 27(12):1567-9. PMID: 23032792; PMCID: PMC4157921.
  16. Tarsy D. Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease. JAMA. 2012 Jun 06; 307(21):2305-14. PMID: 22706836.
    View in: PubMed
  17. Shih LC, Piel J, Warren A, Kraics L, Silver A, Vanderhorst V, Simon DK, Tarsy D. Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders. Parkinsonism Relat Disord. 2012 Jun; 18(5):548-52. PMID: 22436653.
    View in: PubMed
  18. Donovan S, Lim C, Rose P, Tarsy D, Sudarsky LR, Simon DK. The utility of laser-generated visual-cueing in Parkinsonian patients with gait freezing. Parkinsonism Relat Disord. 2012 May; 18(4):401. PMID: 21963184.
    View in: PubMed
  19. Shih LC, Vanderhorst V, Papavassiliou E, Tarsy D. Sustained dyskinesias following elective cessation and reactivation of chronic subthalamic nucleus deep brain stimulation for a surgical procedure. Neuromodulation. 2011 Nov-Dec; 14(6):512-4; discussion 514. PMID: 21854491.
    View in: PubMed
  20. Shih LC, Tarsy D. Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's disease. Neuromodulation. 2011 May-Jun; 14(3):208-13; discussion 213. PMID: 21992241.
    View in: PubMed
  21. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzinska M, Pfeiffer RF, Le C, LeDoux MS. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov Disord. 2011 Feb 15; 26(3):549-52. PMID: 21370264; PMCID: PMC3171986.
  22. Tarsy D, Lungu C, Baldessarini RJ. Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs. Handb Clin Neurol. 2011; 100:601-16. PMID: 21496610.
    View in: PubMed
  23. Chen BR, Patel S, Buckley T, Rednic R, McClure DJ, Shih L, Tarsy D, Welsh M, Bonato P. A web-based system for home monitoring of patients with Parkinson's disease using wearable sensors. IEEE Trans Biomed Eng. 2011 Mar; 58(3):831-6. PMID: 21041152.
    View in: PubMed
  24. Lungu C, Tarulli AW, Tarsy D, Mongiovi P, Vanderhorst VG, Rutkove SB. Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment. Clin Neurophysiol. 2011 May; 122(5):1027-31. PMID: 20943436; PMCID: PMC3044213.
  25. Donovan S, Lim C, Diaz N, Browner N, Rose P, Sudarsky LR, Tarsy D, Fahn S, Simon DK. Laserlight cues for gait freezing in Parkinson's disease: an open-label study. Parkinsonism Relat Disord. 2011 May; 17(4):240-5. PMID: 20817535.
    View in: PubMed
  26. Tarsy D, Sweadner KJ, Song PC. Case records of the Massachusetts General Hospital. Case 17-2010 - a 29-year-old woman with flexion of the left hand and foot and difficulty speaking. N Engl J Med. 2010 Jun 10; 362(23):2213-9. PMID: 20558373.
    View in: PubMed
  27. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet. 2010 Apr; 127(4):470. PMID: 21488252.
    View in: PubMed
  28. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet. 2010 Apr; 127(4):469-70. PMID: 21488296.
    View in: PubMed
  29. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet. 2010 Apr; 127(4):469. PMID: 21488277.
    View in: PubMed
  30. Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet. 2010 Apr; 127(4):470. PMID: 21488298.
    View in: PubMed
  31. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet. 2010 Apr; 127(4):470. PMID: 21488297.
    View in: PubMed
  32. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Dev Batish S, Blitzer A, Pfeiffer RF, Gong S, LeDoux MS. Novel THAP1 sequence variants in primary dystonia. Neurology. 2010 Jan 19; 74(3):229-38. PMID: 20083799; PMCID: PMC2809032.
  33. Patel S, Chen BR, Buckley T, Rednic R, McClure D, Tarsy D, Shih L, Dy J, Welsh M, Bonato P. Home monitoring of patients with Parkinson's disease via wearable technology and a web-based application. Conf Proc IEEE Eng Med Biol Soc. 2010; 2010:4411-4. PMID: 21096462.
    View in: PubMed
  34. Tarsy D. Does subthalamotomy have a place in the treatment of Parkinson's disease? J Neurol Neurosurg Psychiatry. 2009 Sep; 80(9):939-40. PMID: 19684228.
    View in: PubMed
  35. Hausdorff JM, Gruendlinger L, Scollins L, O'Herron S, Tarsy D. Deep brain stimulation effects on gait variability in Parkinson's disease. Mov Disord. 2009 Aug 15; 24(11):1688-92. PMID: 19554569.
    View in: PubMed
  36. Vanderhorst VG, Papavassiliou E, Tarsy D, Shih L. Early brain abscess: A rare complication of deep brain stimulation. Mov Disord. 2009 Jul 15; 24(9):1395-7. PMID: 19412938.
    View in: PubMed
  37. Addy C, Assaid C, Hreniuk D, Stroh M, Xu Y, Herring WJ, Ellenbogen A, Jinnah HA, Kirby L, Leibowitz MT, Stewart RM, Tarsy D, Tetrud J, Stoch SA, Gottesdiener K, Wagner J. Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease. J Clin Pharmacol. 2009 Jul; 49(7):856-64. PMID: 19491335.
    View in: PubMed
  38. Lungu C, Aia PG, Shih LC, Esper CD, Factor SA, Tarsy D. Tardive dyskinesia due to aripiprazole: report of 2 cases. J Clin Psychopharmacol. 2009 Apr; 29(2):185-6. PMID: 19512985.
    View in: PubMed
  39. Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, Zhao Y, LeDoux MS. High-throughput mutational analysis of TOR1A in primary dystonia. BMC Med Genet. 2009 Mar 11; 10:24. PMID: 19284587; PMCID: PMC2661056.
  40. Tarsy D, Simon DK. Beating a dead horse: dopamine and Parkinson disease. Neurology. 2008 Nov 11; 71(20):1651; author reply 1651-2. PMID: 19001260.
    View in: PubMed
  41. Connor GS, Edwards K, Tarsy D. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials. Clin Neuropharmacol. 2008 Mar-Apr; 31(2):97-103. PMID: 18382182.
    View in: PubMed
  42. Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord. 2007 Nov 15; 22(15):2149-55. PMID: 17659638.
    View in: PubMed
  43. Tarsy D. Diabetic gastroparesis. N Engl J Med. 2007 Jul 26; 357(4):419; author reply 419-20. PMID: 17663032.
    View in: PubMed
  44. Tarsy D. Deep-brain stimulation for dystonia: new twists in assessment. Lancet Neurol. 2007 Mar; 6(3):201-2. PMID: 17303521.
    View in: PubMed
  45. Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology. 2006 Dec 26; 67(12):2233-5. PMID: 17190952.
    View in: PubMed
  46. Tarsy D, Simon DK. Dystonia. N Engl J Med. 2006 Aug 24; 355(8):818-29. PMID: 16928997.
    View in: PubMed
  47. Apetauerova D, Ryan RK, Ro SI, Arle J, Shils J, Papavassiliou E, Tarsy D. End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation. Mov Disord. 2006 Aug; 21(8):1277-9. PMID: 16637040.
    View in: PubMed
  48. Bhidayasiri R, Tarsy D. Treatment of dystonia. Expert Rev Neurother. 2006 Jun; 6(6):863-86. PMID: 16784410.
    View in: PubMed
  49. Tarsy D. Initial treatment of Parkinson's disease. Curr Treat Options Neurol. 2006 May; 8(3):224-35. PMID: 16569381.
    View in: PubMed
  50. Tarsy D, Ryan RK, Ro SI. An open-label trial of levetiracetam for treatment of cervical dystonia. Mov Disord. 2006 May; 21(5):734-5. PMID: 16570301.
    View in: PubMed
  51. Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord. 2006 May; 21(5):589-98. PMID: 16532448.
    View in: PubMed
  52. Pahwa R, Lyons KE, Wilkinson SB, Simpson RK, Ondo WG, Tarsy D, Norregaard T, Hubble JP, Smith DA, Hauser RA, Jankovic J. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006 Apr; 104(4):506-12. PMID: 16619653.
    View in: PubMed
  53. Tarsy D, Scollins L, Corapi K, O'Herron S, Apetauerova D, Norregaard T. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor. Stereotact Funct Neurosurg. 2005; 83(5-6):222-7. PMID: 16534254.
    View in: PubMed
  54. Tarsy D, Ro SI. Unusual position-sensitive jaw tremor responsive to botulinum toxin. Mov Disord. 2006 Feb; 21(2):277-8. PMID: 16211606.
    View in: PubMed
  55. Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients. Mov Disord. 2004 Aug; 19(8):916-23. PMID: 15300656.
    View in: PubMed
  56. Okun MS, Fernandez HH, Pedraza O, Misra M, Lyons KE, Pahwa R, Tarsy D, Scollins L, Corapi K, Friehs GM, Grace J, Romrell J, Foote KD. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology. 2004 Jul 13; 63(1):161-3. PMID: 15249630.
    View in: PubMed
  57. Tarsy D, Apetaurova D, Rutkove SB. Palmaris brevis spasm: An occupational syndrome. Neurology. 2004 Mar 09; 62(5):838. PMID: 15007155.
    View in: PubMed
  58. Tarsy D, Apetauerova D, Ryan P, Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology. 2003 Jul 22; 61(2):247-9. PMID: 12874410.
    View in: PubMed
  59. Simon DK, Friedman J, Breakefield XO, Jankovic J, Brin MF, Provias J, Bressman SB, Charness ME, Tarsy D, Johns DR, Tarnopolsky MA. A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics. 2003 Aug; 4(4):199-205. PMID: 12756609.
    View in: PubMed
  60. Press DZ, Mechanic DJ, Tarsy D, Manoach DS. Cognitive slowing in Parkinson's disease resolves after practice. J Neurol Neurosurg Psychiatry. 2002 Nov; 73(5):524-8. PMID: 12397144; PMCID: PMC1738096.
  61. Tarsy D, Indorf G. Tardive tremor due to metoclopramide. Mov Disord. 2002 May; 17(3):620-1. PMID: 12112224.
    View in: PubMed
  62. Sanger TD, Pascual-Leone A, Tarsy D, Schlaug G. Nonlinear sensory cortex response to simultaneous tactile stimuli in writer's cramp. Mov Disord. 2002 Jan; 17(1):105-11. PMID: 11835446.
    View in: PubMed
  63. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs. 2002; 16(1):23-45. PMID: 11772117.
    View in: PubMed
  64. Tarsy D, Thulin PC, Herzog AG. Spasmodic torticollis and reproductive function in women. Parkinsonism Relat Disord. 2001 Oct; 7(4):323-327. PMID: 11344018.
    View in: PubMed
  65. Bhattacharyya N, Tarsy D. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia. Arch Otolaryngol Head Neck Surg. 2001 Apr; 127(4):389-92. PMID: 11296046.
    View in: PubMed
  66. Tarsy D. Re: polyradiculoneuritis after botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol. 2001 Mar-Apr; 24(2):122-3. PMID: 11307052.
    View in: PubMed
  67. Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, Matthews M, Pahwa R, McGuire D, Lew MF, Schuman S, Marek K, Broshjeit S, Factor S, Brown D, Feigin A, Mazurkiewicz J, Ford B, Jennings D, Dilllon S, Comella C, Blasucci L, Janko K, Shulman L, Wiener W, Bateman-Rodriguez D, Carrion A, Suchowersky O, Lafontaine AL, Pantella C, Siemers E, Belden J, Davies R, Lannon M, Grimes D, Gray P, Martin W, Kennedy L, Adler C, Newman S, Hammerstad J, Stone C, Lewitt P, Bardram K, Mistura K, Miyasaki J, Johnston L, Cha JH, Tennis M, Panniset M, Hall J, Tetrud J, Friedlander J, Hauser R, Gauger L, Rodnitzky R, Deleo A, Dobson J, Seeberger L, Dingmann C, Tarsy D, Ryan P, Elmer L, Ruzicka D, Stacy M, Brewer M, Locke B, Baker D, Casaceli C, Day D, Florack M, Hodgeman K, Laroia N, Nobel R, Orme C, Rexo L, Rothenburgh K, Sulimowicz K, Watts A, Wratni E, Tariot P, Cox C, Leventhal C, Alderfer V, Craun AM, Frey J, McCree L, McDermott J, Cooper J, Holdich T, Read B. A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology. 2001 Feb 27; 56(4):455-62. PMID: 11222787.
    View in: PubMed
  68. Sanger TD, Tarsy D, Pascual-Leone A. Abnormalities of spatial and temporal sensory discrimination in writer's cramp. Mov Disord. 2001 Jan; 16(1):94-9. PMID: 11215600.
    View in: PubMed
  69. Tarsy D, Bhattacharyya N, Borodic G. Myasthenia gravis after botulinum toxin A for Meige syndrome. Mov Disord. 2000 Jul; 15(4):736-8. PMID: 10928589.
    View in: PubMed
  70. Tarsy D. Re: parkinsonism and epilepsy: case report and reappraisal of an old question to the editor. Epilepsy Behav. 2000 Jun; 1(3):197-8. PMID: 12609158.
    View in: PubMed
  71. Tarsy D. Tardive Dyskinesia. Curr Treat Options Neurol. 2000 May; 2(3):205-214. PMID: 11096748.
    View in: PubMed
  72. Schachter SC, Tarsy D. Remacemide: current status and clinical applications. Expert Opin Investig Drugs. 2000 Apr; 9(4):871-83. PMID: 11060716.
    View in: PubMed
  73. Tarsy D, First ER. Painful cervical dystonia: clinical features and response to treatment with botulinum toxin. Mov Disord. 1999 Nov; 14(6):1043-5. PMID: 10584688.
    View in: PubMed
  74. Tarsy D. Comparison of acute- and delayed-onset posttraumatic cervical dystonia. Mov Disord. 1998 May; 13(3):481-5. PMID: 9613741.
    View in: PubMed
  75. Tarsy D. Brachial plexus neuropathy after botulinum toxin injection. Neurology. 1997 Oct; 49(4):1176-7. PMID: 9339718.
    View in: PubMed
  76. Koller W, Pahwa R, Busenbark K, Hubble J, Wilkinson S, Lang A, Tuite P, Sime E, Lazano A, Hauser R, Malapira T, Smith D, Tarsy D, Miyawaki E, Norregaard T, Kormos T, Olanow CW. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol. 1997 Sep; 42(3):292-9. PMID: 9307249.
    View in: PubMed
  77. Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology. 1997 Sep; 49(3):701-7. PMID: 9305326.
    View in: PubMed
  78. Tarsy D, Kaufman D, Sethi KD, Rivner MH, Molho E, Factor S. An open-label study of botulinum toxin A for treatment of tardive dystonia. Clin Neuropharmacol. 1997 Feb; 20(1):90-3. PMID: 9037579.
    View in: PubMed
  79. Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord. 1997 Jan; 12(1):100-2. PMID: 8990061.
    View in: PubMed
  80. Pierson SH, Katz DI, Tarsy D. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil. 1996 Jul; 77(7):717-21. PMID: 8670002.
    View in: PubMed
  81. Tarsy D, Miyawaki E. Tardive dystonia after neuroleptic treatment of Tourette's syndrome. J Neurol Neurosurg Psychiatry. 1996 Jul; 61(1):119. PMID: 8676147; PMCID: PMC486481.
  82. Tarsy D. Risperidone and neuroleptic malignant syndrome. JAMA. 1996 Feb 14; 275(6):446. PMID: 8627964.
    View in: PubMed
  83. Tarsy D, Schachter SC. Botulinum toxin treatment is not effective for epilepsy partialis continua. Mov Disord. 1995 May; 10(3):357-8. PMID: 7651461.
    View in: PubMed
  84. Hadley S, Albrecht MA, Tarsy D. Cat-scratch encephalopathy: a cause of status epilepticus and coma in a healthy young adult. Neurology. 1995 Jan; 45(1):196. PMID: 7529901.
    View in: PubMed
  85. Tarsy D, Miyawaki EK. Stiff-man syndrome. Report of a case. Arch Intern Med. 1994 Jun 13; 154(11):1285-8. PMID: 8203996.
    View in: PubMed
  86. Tarsy D, Sudarsky L, Charness ME. Limb dystonia following electrical injury. Mov Disord. 1994 Mar; 9(2):230-2. PMID: 8196690.
    View in: PubMed
  87. O'Donoghue ME, Dangond F, Burger AJ, Suojanen JN, Zarich S, Tarsy D. Spontaneous calcific embolization to the supraclinoid internal carotid artery from a regurgitant bicuspid aortic valve. Neurology. 1993 Dec; 43(12):2715-7. PMID: 8255488.
    View in: PubMed
  88. Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, Schipper HM, Stall G, Dyess E, Tarsy D. Does capsaicin relieve the pain of diabetic neuropathy? Pain. 1990 Sep; 42(3):387-8. PMID: 1701234.
    View in: PubMed
  89. Kershaw P, Freeman R, Templeton D, DeGirolami PC, DeGirolami U, Tarsy D, Hoffmann S, Eliopoulos G, Karchmer AW. Pseudallescheria boydii infection of the central nervous system. Arch Neurol. 1990 Apr; 47(4):468-72. PMID: 2181980.
    View in: PubMed
  90. Spitzer PG, Tarsy D, Eliopoulos GM. Acute transverse myelitis during disseminated cytomegalovirus infection in a renal transplant recipient. Transplantation. 1987 Jul; 44(1):151-3. PMID: 3037738.
    View in: PubMed
  91. Tarsy D. Movement disorders with neuroleptic drug treatment. Psychiatr Clin North Am. 1984 Sep; 7(3):453-71. PMID: 6148742.
    View in: PubMed
  92. Tarsy D, Baldessarini RJ. Tardive dyskinesia. Annu Rev Med. 1984; 35:605-23. PMID: 6144288.
    View in: PubMed
  93. Tarsy D. History and definition of tardive dyskinesia. Clin Neuropharmacol. 1983 Jun; 6(2):91-9. PMID: 6133621.
    View in: PubMed
  94. Tarsy D. Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis. Clin Neuropharmacol. 1983; 6 Suppl 1:S9-26. PMID: 6139168.
    View in: PubMed
  95. Bobruff A, Gardos G, Tarsy D, Rapkin RM, Cole JO, Moore P. Clonazepam and phenobarbital in tardive dyskinesia. Am J Psychiatry. 1981 Feb; 138(2):189-93. PMID: 6109454.
    View in: PubMed
  96. Baldessarini RJ, Tarsy D. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu Rev Neurosci. 1980; 3:23-41. PMID: 6106450.
    View in: PubMed
  97. Baldessarini RJ, Tarsy D. Pathophysiologic basis of tardive dyskinesia. Adv Biochem Psychopharmacol. 1980; 24:451-5. PMID: 6105793.
    View in: PubMed
  98. Bowers MB, Moore D, Tarsy D. Tardive dyskinesia: a clinical test of the supersensitivity hypothesis. Psychopharmacology (Berl). 1979 Mar 22; 61(2):137-41. PMID: 220654.
    View in: PubMed
  99. Baldessarini RJ, Tarsy D. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. Int Rev Neurobiol. 1979; 21:1-45. PMID: 43842.
    View in: PubMed
  100. Gardos G, Cole JO, Tarsy D. Withdrawal syndromes associated with antipsychotic drugs. Am J Psychiatry. 1978 Nov; 135(11):1321-4. PMID: 30287.
    View in: PubMed
  101. Tarsy D, Mahoney JF, Cummings JL. Physostigmine in Wilson disease. Ann Neurol. 1978 Apr; 3(4):372-3. PMID: 666284.
    View in: PubMed
  102. Pycock C, Milson J, Tarsy D, Marsden CD. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system. Neuropharmacology. 1978 Mar; 17(3):175-83. PMID: 565479.
    View in: PubMed
  103. Tarsy D, Pycock CJ, Meldrum BS, Marsden CD. Focal contralateral myoclonus produced by inhibition of GABA action in the caudate nucleus of rats. Brain. 1978 Mar; 101(1):143-62. PMID: 638722.
    View in: PubMed
  104. Romanul FC, Radvany J, Fowler HL, Tarsy D. Azorean disease of the nervous system: report of six additional families. Trans Am Neurol Assoc. 1978; 103:269-73. PMID: 757075.
    View in: PubMed
  105. Tarsy D, Bralower M. Deanol acetamidobenzoate treatment in choreiform movement disorders. Arch Neurol. 1977 Dec; 34(12):756-8. PMID: 145212.
    View in: PubMed
  106. Tarsy D, Granacher R, Bralower M. Tardive dyskinesia in young adults. Am J Psychiatry. 1977 Sep; 134(9):1032-4. PMID: 409302.
    View in: PubMed
  107. Tarsy D, Lieberman B, Chirico-Post J, Benson F. Unilateral asterixis associated with a mesencephalic syndrome. Arch Neurol. 1977 Jul; 34(7):446-7. PMID: 880071.
    View in: PubMed
  108. Tarsy D, Baldessarini RJ. The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry. 1977 Jun; 12(3):431-50. PMID: 194633.
    View in: PubMed
  109. Galea-Debono A, Jenner P, Marsden CD, Parkes JD, Tarsy D, Walters J. Plasma DOPA levels and growth hormone response to levodopa in parkinsomism. J Neurol Neurosurg Psychiatry. 1977 Feb; 40(2):162-7. PMID: 864480; PMCID: PMC492632.
  110. Pycock C, Milson JA, Tarsy D, Marsden CD. The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic nerve terminals. J Pharm Pharmacol. 1976 Jun; 28(6):530-2. PMID: 7659.
    View in: PubMed
  111. Baldessarini RJ, Tarsy D. Mechanisms underlying tardive dyskinesia. Res Publ Assoc Res Nerv Ment Dis. 1976; 55:433-46. PMID: 826999.
    View in: PubMed
  112. Pycock C, Tarsy D, Marsden CD. Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum. Psychopharmacologia. 1975 Dec 31; 45(2):211-9. PMID: 1240638.
    View in: PubMed
  113. Marsden CD, Milson J, Parkes JD, Pycock C, Tarsy D. Proceedings: The effect of cholinergic and anticholinergic drugs on rotational behaviour in mice with destruction of one nigrostriatal pathway. J Physiol. 1975 Jul; 249(1):64P-65P. PMID: 1151886.
    View in: PubMed
  114. Pycock CJ, Tarsy D, Marsden CD. Inhibition of turning behaviour by clozapine in mice with unilateral destruction of dopaminergic nerve terminals. J Pharm Pharmacol. 1975 Jun; 27(6):445-7. PMID: 237097.
    View in: PubMed
  115. Tarsy D, Parkes JD, Marsden CD. Letter: Metoclopramide in parkinsonism. Lancet. 1975 May 31; 1(7918):1244-5. PMID: 48872.
    View in: PubMed
  116. Tarsy D, Pycock C, Meldrum B, Marsden CD. Rotational behavior induced in rats by intranigral picrotoxin. Brain Res. 1975 May 16; 89(1):160-5. PMID: 1148841.
    View in: PubMed
  117. Tarsy D, Parkes JD, Marsden CD. Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias. J Neurol Neurosurg Psychiatry. 1975 Apr; 38(4):331-5. PMID: 1095689; PMCID: PMC491929.
  118. Marsden CD, Meldrum BS, Pycock C, Tarsy D. Focal myoclonus produced by injection of picrotoxin into the caudate nucleus of the rat. J Physiol. 1975 Mar; 246(2):96P. PMID: 1142296.
    View in: PubMed
  119. Parkes JD, Tarsy D, Marsden CD, Bovill KT, Phipps JA, Rose P, Asselman P. Amphetamines in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1975 Mar; 38(3):232-7. PMID: 1097600; PMCID: PMC491901.
  120. Tarsy D, Parkes JD, Marsden CD. Clonidine in Parkinson disease. Arch Neurol. 1975 Feb; 32(2):134-6. PMID: 1122178.
    View in: PubMed
  121. Dolphin A, Jenner P, Marsden CD, Pycock C, Tarsy D. Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents. Psychopharmacologia. 1975; 41(2):133-8. PMID: 1171487.
    View in: PubMed
  122. Marsden CD, Duvoisin RC, Jenner P, Parkes JD, Pycock C, Tarsy D. Relationship between animal models and clinical parkinsonism. Adv Neurol. 1975; 9:165-75. PMID: 1146651.
    View in: PubMed
  123. Tarsy D. Letter: Deanol in tardive dyskinesia. N Engl J Med. 1974 Dec 26; 291(26):1416. PMID: 4427649.
    View in: PubMed
  124. Tarsy D, Baldessarini RJ. Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology. 1974 Nov; 13(10-11):927-40. PMID: 4474641.
    View in: PubMed
  125. Marsden CD, Dolphin A, Duvoisin RC, Jenner P, Tarsy D. Role of noradrenaline in levodopa reversal of reserpine akinesia. Brain Res. 1974 Sep 13; 77(3):521-5. PMID: 4854165.
    View in: PubMed
  126. Tarsy D, Leopold N, Sax DS. Physostigmine in choreiform movement disorders. Neurology. 1974 Jan; 24(1):28-33. PMID: 4358998.
    View in: PubMed
  127. Tarsy D, Baldessarini RJ. Pharmacologically induced behavioural supersensitivity to apomorphine. Nat New Biol. 1973 Oct 31; 245(148):262-3. PMID: 4518989.
    View in: PubMed
  128. Tarsy D, Holden EM, Segarra JM, Calabresi P, Feldman RG. 5-Iodo-2'-deoxyuridine (IUDR; NSC-39661) given intraventricularly in the treatment of progressive multifocal leukoencephalopathy. Cancer Chemother Rep. 1973 Feb; 57(1):73-8. PMID: 4122235.
    View in: PubMed
  129. Tarsy D, Leopold N, Sax DS. Cholinergic-adrenergic hypothesis of mania and depression. Lancet. 1972 Nov 25; 2(7787):1153. PMID: 4117233.
    View in: PubMed
  130. Tarsy D. Glycerol in acute cerebral infarction. Lancet. 1971 Dec 11; 2(7737):1322. PMID: 4143570.
    View in: PubMed
  131. Sax DS, Tarsy D. Side effects of L-dopa. N Engl J Med. 1971 Oct 28; 285(18):1033. PMID: 5094818.
    View in: PubMed
  132. Tarsy D. Abbreviated specialty training. N Engl J Med. 1970 Mar 19; 282(12):694. PMID: 5437537.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Tarsy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_